Andreas Halvorsen’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Andreas Halvorsen’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,532,119	Closed	-$51.1M	–	97
2025 Q3	$51.1M	Sell	2,532,119 -9,149,214	-78%	-$161M	0.13%	72
2025 Q2	$196M	Buy	11,681,333 +1,555,855	+15%	+$25.1M	0.57%	57
2025 Q1	$156M	Buy	10,125,478 +3,621,993	+56%	+$64.7M	0.49%	59
2024 Q4	$143M	Sell	6,503,485 -1,064,048	-14%	-$19.4M	0.46%	54
2024 Q3	$136M	Buy	+7,567,533	New	+$132M	0.5%	53
2016 Q4	–	Sell	-19,684,219	Closed	-$906M	–	77
2016 Q3	$906M	Sell	19,684,219 -8,052,436	-29%	-$420M	3.91%	6
2016 Q2	$1.39B	Sell	27,736,655 -5,234,967	-16%	-$279M	5.92%	4
2016 Q1	$1.76B	Buy	32,971,622 +7,927,847	+32%	+$465M	7.77%	3
2015 Q4	$1.64B	Buy	25,043,775 +16,171,125	+182%	+$999M	6.2%	4
2015 Q3	$501M	Buy	+8,872,650	New	+$575M	1.92%	16
2015 Q2	–	Sell	-228,600	Closed	-$14.2M	–	68
2015 Q1	$14.2M	Buy	+228,600	New	+$13.3M	0.06%	55

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Andreas Halvorsen's TEVA Position: Q4 2025 in Review

Andreas Halvorsen sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2025, closing a stake of 2,532,119 shares — an estimated $51.1M sold.

Andreas Halvorsen first reported a position in TEVA in Q1 2015 and held it in 11 quarters. The position peaked at $1.76B in Q1 2016. 636 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

Andreas Halvorsen reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2025 after selling out during the quarter.
Andreas Halvorsen sold 2,532,119 Teva Pharmaceutical Industries Limited shares in Q4 2025, an estimated $51.1M.
Andreas Halvorsen first reported a position in Teva Pharmaceutical Industries Limited in Q1 2015 and held it in 11 quarters.
Andreas Halvorsen's Teva Pharmaceutical Industries Limited position peaked at $1.76B in Q1 2016.
636 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2025.

Based on Viking Global Investors's 13F filing for Q4 2025, filed 17 Feb 2026.